Physician profile
Natalia Balytsky
NPI 1326146705
$2,505.88
in general payments reported to CMS, 2019-2025
11 companies · $570 in 2025
The $570 reported for 2025 was more than what 91% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $106 · 2021: $219 · 2022: $431 · 2023: $380 · 2024: $650 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,599.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $2,135.96 | 2019-2025 | |
| Pfizer INC. | $82.35 | 2019-2021 | |
| Abbvie INC. | $59.12 | 2025 | |
| Collegium Pharmaceutical, INC. | $41.80 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $41.16 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $37.88 | 2019 | |
| Grt US Holding, INC. | $34.10 | 2022 | |
| Saluda Medical Americas, INC. | $28.69 | 2025 | Evoke |
| Biodelivery Sciences International, INC. | $18.40 | 2021 | |
| Depuy Synthes Sales INC. | $14.68 | 2021 | |
| Orthogenrx INC. | $11.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalia Balytsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.